Arginine methyltransferases in normal and malignant hematopoiesis

Experimental Hematology

Volumn 44, Issue 6, 2016, Pages 435-441

  Greenblatt, Sarah M ^a   Liu, Fan ^a   Nimer, Stephen D ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; DNA; HISTONE DEACETYLASE 1; MIXED LINEAGE LEUKEMIA PROTEIN; N(G) METHYLARGININE; PRMT4 PROTEIN; PRMT5 PROTEIN; PRMT6 PROTEIN; PRMT7 PROTEIN; PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN P53; PROTEIN SM; PROTEIN SWI; RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SIN3A; TRANSCRIPTION FACTOR SNF; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; ISOPROTEIN; PRMT2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ACUTE MYELOBLASTIC LEUKEMIA; CATALYSIS; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL SELF-RENEWAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA REPAIR; ENZYME MODIFICATION; EPIGENETICS; GENE LOCUS; GENETIC TRANSCRIPTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HISTONE MODIFICATION; HUMAN; MALIGNANT HEMATOPOIESIS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA PROCESSING; RNA TRANSLATION; ANIMAL; BLOOD; BLOOD CELL; CYTOLOGY; GENE EXPRESSION; GENETICS; HEMATOLOGIC DISEASE; METABOLISM; METHYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD CELLS; CELL DIFFERENTIATION; CELL SELF RENEWAL; DNA REPAIR; GENE EXPRESSION; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; METHYLATION; PROTEIN ISOFORMS; PROTEIN-ARGININE N-METHYLTRANSFERASES; SIGNAL TRANSDUCTION;

EID: 84964957431     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2016.03.009     Document Type: Review

References (72)

1. Geoghegan V., Guo A., Trudgian D., Thomas B., Acuto O. Comprehensive identification of arginine methylation in primary T cells reveals regulatory roles in cell signalling. Nature Commun 2015, 6:6758.
2. Shia W.J., Okumura A.J., Yan M., et al. PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential. Blood 2012, 119:4953-4962.
3. Zou L., Zhang H., Du C., et al. Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia. J Hematol Oncol 2012, 5:42.
4. Leonard S., Gordon N., Smith N., Rowe M., Murray P.G., Woodman C.B. Arginine methyltransferases are regulated by Epstein-Barr virus in B cells and are differentially expressed in Hodgkin's lymphoma. Pathogens 2012, 1:52-64.
5. Yoshimatsu M., Toyokawa G., Hayami S., et al. Dysregulation of PRMT1 and PRMT6, type I arginine methyltransferases, is involved in various types of human cancers. Int J Cancer 2011, 128:562-573.
6. Vu L.P., Perna F., Wang L., et al. PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex. Cell Rep 2013, 5:1625-1638.
7. Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z., Liu H., et al. A comprehensive transcriptional portrait of human cancer cell lines. Nat Biotechnol 2015, 33:306-312.
8. Wang L., Pal S., Sif S. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol Cell Biol 2008, 28:6262-6277.
9. Pal S., Baiocchi R.A., Byrd J.C., Grever M.R., Jacob S.T., Sif S. Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO J 2007, 26:3558-3569.
10. Pawlak M.R., Scherer C.A., Chen J., Roshon M.J., Ruley H.E. Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol Cell Biol 2000, 20:4859-4869.
11. Tang J., Frankel A., Cook R.J., et al. PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J Biol Chem 2000, 275:7723-7730.
12. Huang S., Litt M., Felsenfeld G. Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. Genes Dev 2005, 19:1885-1893.
13. An W., Kim J., Roeder R.G. Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 2004, 117:735-748.
14. Zhao X., Jankovic V., Gural A., et al. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev 2008, 22:640-653.
15. Mizutani S., Yoshida T., Zhao X., Nimer S.D., Taniwaki M., Okuda T. Loss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasis. Br J Haematol 2015, 170:859-873.
16. Cheung N., Chan L.C., Thompson A., Cleary M.L., So C.W. Protein arginine-methyltransferase-dependent oncogenesis. Nat Cell Biol 2007, 9:1208-1215.
17. Cheung N., Fung T.K., Zeisig B.B., et al. Targeting aberrant epigenetic networks mediated by PRMT1 and KDM4C in acute myeloid leukemia. Cancer Ccell 2016, 29:32-48.
18. Yoshida K., Sanada M., Shiraishi Y., et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011, 478:64-69.
19. Zhang L., Tran N.T., Su H., et al. Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing. eLife 2015, 4.
20. O'Brien K.B., Alberich-Jorda M., Yadav N., et al. CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells. Development 2010, 137:2147-2156.
21. Kim J., Lee J., Yadav N., et al. Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development. J Biol Chem 2004, 279:25339-25344.
22. Torres-Padilla M.E., Parfitt D.E., Kouzarides T., Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 2007, 445:214-218.
23. Wu Q., Bruce A.W., Jedrusik A., et al. CARM1 is required in embryonic stem cells to maintain pluripotency and resist differentiation. Stem Cells 2009, 27:2637-2645.
24. Kawabe Y., Wang Y.X., McKinnell I.W., Bedford M.T., Rudnicki M.A. Carm1 regulates Pax7 transcriptional activity through MLL1/2 recruitment during asymmetric satellite stem cell divisions. Cell Stem Cell 2012, 11:333-345.
25. Feng Q., Yi P., Wong J., O'Malley B.W. Signaling within a coactivator complex: Methylation of SRC-3/AIB1 is a molecular switch for complex disassembly. Mol Cell Biol 2006, 26:7846-7857.
26. Cheng D., Cote J., Shaaban S., Bedford M.T. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol Cell 2007, 25:71-83.
27. Wang L., Zhao Z., Meyer M.B., et al. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. Cancer Cell 2014, 25:21-36.
28. Kowenz-Leutz E., Pless O., Dittmar G., Knoblich M., Leutz A. Crosstalk between C/EBPbeta phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code. EMBO J 2010, 29:1105-1115.
29. Branscombe T.L., Frankel A., Lee J.H., et al. PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem 2001, 276:32971-32976.
30. Pollack B.P., Kotenko S.V., He W., Izotova L.S., Barnoski B.L., Pestka S. The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J Biol Chem 1999, 274:31531-31542.
31. Bandyopadhyay S., Harris D.P., Adams G.N., et al. HOXA9 methylation by PRMT5 is essential for endothelial cell expression of leukocyte adhesion molecules. Mol Cell Biol 2012, 32:1202-1213.
32. Jansson M., Durant S.T., Cho E.C., et al. Arginine methylation regulates the p53 response. Nat Cell Biol 2008, 10:1431-1439.
33. Le Guezennec X., Vermeulen M., Brinkman A.B., et al. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol 2006, 26:843-851.
34. Meister G., Eggert C., Buhler D., Brahms H., Kambach C., Fischer U. Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr Biol 2001, 11:1990-1994.
35. Karkhanis V., Hu Y.J., Baiocchi R.A., Imbalzano A.N., Sif S. Versatility of PRMT5-induced methylation in growth control and development. Trends Biochem Sci 2011, 36:633-641.
36. Meister G., Fischer U. Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs. EMBO J 2002, 21:5853-5863.
37. Neuenkirchen N., Chari A., Fischer U. Deciphering the assembly pathway of Sm-class U snRNPs. FEBS Lett 2008, 582:1997-2003.
38. Bezzi M., Teo S.X., Muller J., et al. Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery. Genes Dev 2013, 27:1903-1916.
39. Koh C.M., Bezzi M., Low D.H., et al. MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis. Nature 2015, 523:96-100.
40. Wei T.Y., Juan C.C., Hisa J.Y., et al. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade. Cancer Sci 2012, 103:1640-1650.
41. Antonysamy S., Bonday Z., Campbell R.M., et al. Crystal structure of the human PRMT5:MEP50 complex. Proc Natl Acad Sci USA 2012, 109:17960-17965.
42. Guderian G., Peter C., Wiesner J., et al. RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity. J Biol Chem 2011, 286:1976-1986.
43. Lacroix M., El Messaoudi S., Rodier G., Le Cam A., Sardet C., Fabbrizio E. The histone-binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5. EMBO Rep 2008, 9:452-458.
44. Liu F., Zhao X., Perna F., et al. JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. Cancer Cell 2011, 19:283-294.
45. Gu Z., Li Y., Lee P., Liu T., Wan C., Wang Z. Protein arginine methyltransferase 5 functions in opposite ways in the cytoplasm and nucleus of prostate cancer cells. PloS One 2012, 7(8):e44033.
46. Chittka A., Nitarska J., Grazini U., Richardson W.D. Transcription factor positive regulatory domain 4 (PRDM4) recruits protein arginine methyltransferase 5 (PRMT5) to mediate histone arginine methylation and control neural stem cell proliferation and differentiation. J Biol Chem 2012, 287:42995-43006.
47. Tee W.W., Pardo M., Theunissen T.W., et al. Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency. Genes Dev 2010, 24:2772-2777.
48. Liu F., Cheng G., Hamard P.J., et al. Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis. J Clin Invest 2015, 125:3532-3544.
49. Stopa N., Krebs J.E., Shechter D. The PRMT5 arginine methyltransferase: Many roles in development, cancer and beyond. Cell Mol Life Sci 2015, 72:2041-2059.
50. Bao X., Zhao S., Liu T., Liu Y., Liu Y., Yang X. Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer. J Histochem Cytochem 2013, 61:206-217.
51. Li Y., Chitnis N., Nakagawa H., et al. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers. Cancer Discovery 2015, 5:288-303.
52. Chan-Penebre E., Kuplast K.G., Majer C.R., et al. A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models. Nat Chem Biol 2015, 11:432-437.
53. Tarighat S.S., Santhanam R., Frankhouser D., et al. The dual epigenetic role of PRMT5 in acute myeloid leukemia: Gene activation and repression via histone arginine methylation. Leukemia 2016, 30:789-799.
54. Kryukov G.V., Wilson F.H., Ruth J.R., et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science 2016, 351:1214-1218.
55. Mavrakis K.J., McDonald E.R., Schlabach M.R., et al. Disordered methionine metabolism in MTAP/CDKN2A deleted cancers leads to dependence on PRMT5. Science 2016, 351:1208-1213.
56. Guccione E., Bassi C., Casadio F., et al. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007, 449:933-937.
57. Hyllus D., Stein C., Schnabel K., et al. PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev 2007, 21:3369-3380.
58. Iberg A.N., Espejo A., Cheng D., et al. Arginine methylation of the histone H3 tail impedes effector binding. J Biol Chem 2008, 283:3006-3010.
59. Lee Y.H., Ma H., Tan T.Z., et al. Protein arginine methyltransferase 6 regulates embryonic stem cell identity. Stem Cells Dev 2012, 21:2613-2622.
60. Herglotz J., Kuvardina O.N., Kolodziej S., et al. Histone arginine methylation keeps RUNX1 target genes in an intermediate state. Oncogene 2013, 32:2565-2575.
61. Kuvardina O.N., Herglotz J., Kolodziej S., et al. RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation. Blood 2015, 125:3570-3579.
62. Neault M., Mallette F.A., Vogel G., Michaud-Levesque J., Richard S. Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor. Nucleic Acids Res 2012, 40:9513-9521.
63. Phalke S., Mzoughi S., Bezzi M., et al. p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Res 2012, 40:9534-9542.
64. Zurita-Lopez C.I., Sandberg T., Kelly R., Clarke S.G. Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming omega-NG-monomethylated arginine residues. J Biol Chem 2012, 287:7859-7870.
65. Koscielny G., Yaikhom G., Iyer V., et al. The International Mouse Phenotyping Consortium Web Portal, a unified point of access for knockout mice and related phenotyping data. Nucleic Acids Res 2014, 42(Database issue):D802-D809.
66. Bleibel W.K., Duan S., Huang R.S., et al. Identification of genomic regions contributing to etoposide-induced cytotoxicity. Hum Genet 2009, 125:173-180.
67. Gros L., Renodon-Corniere A., de Saint Vincent B.R., Feder M., Bujnicki J.M., Jacquemin-Sablon A. Characterization of prmt7alpha and beta isozymes from Chinese hamster cells sensitive and resistant to topoisomerase II inhibitors. Biochim Biophys Acta 2006, 1760:1646-1656.
68. Verbiest V., Montaudon D., Tautu M.T., et al. Protein arginine (N)-methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins. FEBS Lett 2008, 582:1483-1489.
69. Karkhanis V., Wang L., Tae S., Hu Y.J., Imbalzano A.N., Sif S. Protein arginine methyltransferase 7 regulates cellular response to DNA damage by methylating promoter histones H2A and H4 of the polymerase delta catalytic subunit gene, POLD1. J Biol Chem 2012, 287:29801-29814.
70. Gonsalvez G.B., Tian L., Ospina J.K., Boisvert F.M., Lamond A.I., Matera A.G. Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins. J Cell Biol 2007, 178:733-740.
71. Dhar S.S., Lee S.H., Kan P.Y., et al. Trans-tail regulation of MLL4-catalyzed H3K4 methylation by H4R3 symmetric dimethylation is mediated by a tandem PHD of MLL4. Genes Dev 2012, 26:2749-2762.
72. Ying Z., Mei M., Zhang P., et al. Histone arginine methylation by PRMT7 controls germinal center formation via regulating Bcl6 transcription. J Immunol 2015, 195:1538-1547.